Concentrix fell 8.0% from $32.91 to $30.27, behind the S&P 500's +10.2%. Its worst day was Mar 24 (−19.9%), and its low came Jul 9 at $20.97.
Story events cover the past 12 months · Times ET
Nov 19, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $2.95 beat the $2.75 estimate on $2.6B revenue (est. $2.5B); FY revenue guidance of $10.0B–$10.2B against the $10.1B consensus.
−3.2% · S&P 500 −0.2%
Concentrix shares fell 12.7%, while the S&P 500 fell 0.0%.
−12.7% · S&P 500 0.0%
Concentrix shares fell 13.0%, while the S&P 500 fell 1.5%.
−13.0% · S&P 500 −1.5%
EPS of $2.61 beat the $2.52 estimate on $2.5B revenue (est. $2.5B); FY revenue guidance of $10.0B–$10.2B against the $10.1B consensus.
−19.9%, the year's worst day · S&P 500 −0.3%
EPS of $2.63 beat the $2.57 estimate on $2.5B revenue (est. $2.5B); FY revenue guidance of $9.9B–$10.0B against the $10.1B consensus.
−11.2% · S&P 500 +0.8%
Concentrix closed at its lowest level of the year, 36.3% below where the year started.
−1.9% · S&P 500 +0.8%
Concentrix shares fell 12.1%, while the S&P 500 fell 0.5%.
−12.1% · S&P 500 −0.5%
EPS of $2.92 beat the $2.73 estimate on $2.5B revenue (est. $2.5B); FY revenue guidance of $9.8B–$9.9B against the $10.0B consensus.
+0.3% · S&P 500 −0.2%
Concentrix shares rose 12.5%, while the S&P 500 fell 1.2%.
+12.5%, the year's best day · S&P 500 −1.2%
Where it ended: a close of $30.27 on Nov 18, 2026. Up next: Q4 2026 earnings on Jan 12, 2027 (EPS est. $2.85, revenue est. $2.4B).
